Dr. Meifeng Xu
University of Cincinnati Medical Center, USA
Email: [email protected]
Qualifications
1995-1999 Ph.D., Biological Sciences, The Hong Kong
Polytechnic University, Hong Kong, P. R. of China
1986-1989 M.Sc., Pharmacology, Suzhou Medical College, P.
R. of China
1977-1982 M.D., Medicine, Suzhou Medical College, P. R. of
China
Publications (Selected)
-
Wang, B., He, X., Dutta, S., Chen, S., Liang, J., Huang, W., ... & Wang, Y. (2025). New progress and challenges of targeted therapies for breast cancer. Annals of Palliative Medicine, 14(4), 34552-34352.
-
Cai, W. F., Jiang, L., Liang, J., Dutta, S., Huang, W., He, X., ... & Wang, Y. (2024). Hax1-overexpression augments cardioprotective efficacy of stem cell-based therapy through mediating hippo-yap signaling. Stem Cell Reviews and Reports, 20(6), 1569-1586.
-
He, X., Dutta, S., Liang, J., Paul, C., Huang, W., Xu, M., ... & Wang, Y. (2023). Direct cellular reprogramming techniques for cardiovascular regenerative therapeutics. Canadian Journal of Physiology and Pharmacology, 102(1), 1-13.
-
Gong, M., Wang, M., Xu, J., Yu, B., Wang, Y. G., Liu, M., ... & Xu, M. (2022). Nano-sized extracellular vesicles secreted from GATA-4 modified mesenchymal stem cells promote angiogenesis by delivering Let-7 miRNAs. Cells, 11(9), 1573.
-
Jiang, L., Liang, J., Huang, W., Ma, J., Park, K. H., Wu, Z., ... & Wang, Y. (2022). CRISPR activation of endogenous genes reprograms fibroblasts into cardiovascular progenitor cells for myocardial infarction therapy. Molecular Therapy, 30(1), 54-74.
-
Wu, Z., Liang, J., Huang, W., Jiang, L., Paul, C., Gao, X., ... & Wang, Y. (2021). Immunomodulatory effects of mesenchymal stem cells for the treatment of cardiac allograft rejection. Experimental Biology and Medicine, 246(7), 851-860.
-
Wang, J., Gong, M., Zuo, S., Xu, J., Paul, C., Li, H., ... & Xu, M. (2020). WNT11-conditioned medium promotes angiogenesis through the activation of non-canonical WNT-PKC-JNK signaling pathway. Genes, 11(11), 1277.
-
Gong, M., Yu, B., Wang, J., Wang, Y., Liu, M., Paul, C., ... & Xu, M. (2017). Mesenchymal stem cells release exosomes that transfer miRNAs to endothelial cells and promote angiogenesis. Oncotarget, 8(28), 45200.
-
Wu, S. Z., Li, Y. L., Huang, W., Cai, W. F., Liang, J., Paul, C., ... & Wang, Y. (2017). Paracrine effect of CXCR4‐overexpressing mesenchymal stem cells on ischemic heart injury. Cell biochemistry and function, 35(2), 113-123.
-
Liu, H., Qin, W., Wang, Z., Shao, Y., Wang, J., Borg, T. K., ... & Xu, M. (2016). Disassembly of myofibrils and potential imbalanced forces on Z‐discs in cultured adult cardiomyocytes. Cytoskeleton, 73(5), 246-257.
-
Yu, B., Yang, Y., Liu, H., Gong, M., Millard, R. W., Wang, Y. G., ... & Xu, M. (2016). Clusterin/Akt up-regulation is critical for GATA-4 mediated cytoprotection of mesenchymal stem cells against ischemia injury. PloS one, 11(3), e0151542.
-
Liang, J., Huang, W., Cai, W., Xu, M., Paul, C., Millard, R., & Wang, Y. (2015). Microrna-495 Mediates the Angiogenic Potential of iPSC-Derived Endothelial Cells in Infarcted Heart. Circulation, 132(suppl_3), A14690-A14690.
-
Yu, B., Yang, Y., Wang, Y. G., Millard, R., Ashraf, M., & Xu, M. (2015). Clusterin Up-regulation and Akt Pathway Activation Are Key to GATA-4 Mediated Cytoprotection of Mesenchymal Stem Cells Against Ischemia Injury. Circulation, 132(suppl_3), A10808-A10808.
-
Guo, L., Liang, J., Huang, W., Cai, W., Wang, L., Wang, J., ... & Wang, Y. (2015). Electrical Stimulation Upregulates the miR-99 Family to Promote Cardiac Differentiation and Maturation of Human iPS Cells. Circulation, 132(suppl_3), A13646-A13646.
Profile Details
https://med.uc.edu/landing-pages/profile/Index/Pubs/xume
https://www.researchgate.net/profile/Meifeng-Xu